Edwards Affirms 2021 Outlook
January 27 2021 - 5:14PM
Dow Jones News
By Allison Prang
Edwards Lifesciences Corp. affirmed its outlook for 2021.
The medical-device company said it still expects adjusted
earnings to be between $2 and $2.20 a share. It also still expects
between $4.9 billion and $5.3 billion in sales. According to
FactSet, analysts are expecting $2.14 in adjusted earnings.
Edwards also said it expects between $1.1 billion and $1.2
billion in sales this quarter. For adjusted earnings, it is
expecting between 43 cents a share and 50 cents a share. Analysts
are expecting 50 cents a share in adjusted earnings.
Write to Allison Prang at allison.prang@wsj.com
(END) Dow Jones Newswires
January 27, 2021 16:59 ET (21:59 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Aug 2024 to Sep 2024
Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Sep 2023 to Sep 2024